Structured treatment.Longitudinal care.

Pen helps men start treatment with structured intake, clinician-reviewed decisions, medication access, and follow-up that carries their health context forward.

Hair loss is the first workflow. The same model can expand into adjacent categories like sexual health and metabolic care over time.

See how Pen works →
Why this matters for Soficca
Week 6

You're on track.

Your next refill ships in 4 days.

Current treatment
Finasteride + Minoxidil: daily routine
View your full plan →
The Problem

Access is only the beginning. Care is still fragmented.

Getting access is not enough. The harder problem is continuity: patient context, safety, treatment response, adherence, and follow-up are often disconnected after the first visit.

Fragmented context
Health context is collected once, then often lost across follow-up and treatment decisions.
Disconnected follow-up
Patients begin treatment, but ongoing safety, adherence, and response signals rarely move forward cleanly.
What We Learned

50+ real intakes reshaped the product

What early cases made clear

Early user intakes exposed where patients hesitate, what safety context matters, and what follow-up needs to carry forward. Those signals shaped Pen around continuity, not just conversion.

01
Decision friction
Users need clarity on what happens after they submit health context.
02
Safety context
Contraindications, concerns, and history need to be captured before treatment.
03
Follow-up signals
Progress, adherence, and response need to remain connected across reviews.
How Pen Works

From intake to treatment to follow-up

Pen structures the care journey from first intake to follow-up checkpoints, creating a longitudinal record that can support safer reviews over time.

Tell us about you
Guided intake
Users submit symptoms, goals, history, and safety context before treatment.
Reviewing your case
Decision layer
Soficca routes the case through governed eligibility and safety logic.
Your plan is ready
Finasteride + Minoxidil
Treatment path
Users receive a clinician-reviewed treatment path designed for continuity.
Check-in: Week 6
Week 6
Follow-up over time
Checkpoints carry adherence, response, and safety context forward.
Lifestyle Line Art
Lifestyle

Care designed around your life

Treatment that fits into your routine, not the other way around.

View live Pen demo →
Why Pen Is Different

Hair loss is the wedge. The workflow is the platform.

Hair loss is the first high-intent treatment journey. The same workflow (intake, eligibility logic, safety screening, medication access, clinician review, and follow-up) can support additional longitudinal categories over time.

Core Mechanism

Repeatable care flow

The core pattern is reusable: intake → decision → treatment → follow-up.

What This Enables
Adjacent categories
The same model can extend into areas like sexual health and metabolic care.
Medication access
Fulfillment can run through licensed pharmacy and laboratory partners.
Longitudinal context
Each review carries history, safety signals, adherence, and treatment response forward.
Business Model

Monetized through treatment. Compounding through context.

Pen can begin with paid treatment journeys and medication access through licensed partners. Over time, the model can support Pen-branded treatment lines with allied licensed laboratories as demand, validation, and partnerships grow.

$24/month
Starting price · Latin America
Treatment revenue
Paid treatment journeys tied to real user intent.
Licensed partners
Medication fulfillment and development through licensed pharmacy and laboratory partners.
Branded treatment lines
Potential Pen-branded medication lines as demand, validation, and licensed partnerships grow.
Clinical context layer
Structured longitudinal data across symptoms, safety, adherence, treatment response, and outcomes.
Early Execution

Built fast. Grounded in real use.

Pen has moved quickly from static concept to a working product flow, using real intake behavior to sharpen the treatment journey, safety logic, and follow-up model.

50+ real intakes completed
Real users, real decision outputs, real data. Not simulations.
First workflow live
Pen is operational with governed intake, decision logic, and clinician review.
Built from November 2025 to April 2026
Product, infrastructure, and care flow designed and deployed in under six months.
Clinical audit & regulatory advisor onboarded
Advisory support for documentation discipline, audit-readiness, and regulatory alignment.
Advisory Support

Clinical audit & regulatory advisor

Pen is designed to support clinician-reviewed care with structured intake, safety context, decision traceability, and audit-ready records.

Carlos Pérez
Role: Clinical Audit & Regulatory Advisor

10+ years in healthcare operations and regulatory processes in Colombia. Currently at Nueva EPS. Advises Soficca on documentation discipline, audit-readiness, and regulatory alignment.

Why This Matters

Pen is the first workflow. Soficca is the decision layer underneath.

Pen proves the first repeatable treatment workflow: capture structured patient context, route decisions through governed logic, support clinician review, enable medication access through licensed partners, and carry the case forward over time.

Soficca is the decision infrastructure designed to generalize beyond hair loss.

First workflow → repeatable care infrastructure

Pen validates the wedge. Soficca carries the decision logic, safety trace, and longitudinal context that can generalize beyond hair loss.

See Soficca →